Sarah Sutton, PhD, has a decade of experience in scientific communications, having worked as a journalist, an author on academic papers, and behind the scenes as a media strategist. Prior to joining Ten Bridge, Sarah led writing projects for the Broad Institute's fundraising team, helping to secure millions of dollars in grants and private funding for biomedical research. Previously, she managed web and media communications for Brown University's Alumni Relations team, serving as project manager, editor, and writer for a range of communications initiatives designed to enhance ties between the university and its constituents. She also spent several years as a medico-legal researcher at a small consulting firm, where she co-authored medical journal articles and consulted for mass-tort litigators in class-action environmental and occupational health lawsuits. Sarah is an experienced writing instructor, and she spent five years teaching undergraduate courses in science writing at Brandeis University, where she also directed the university's writing center. Sarah began her career as a journalist at the Glens Falls (N.Y.) Post-Star, covering business and environmental issues. Her writing has appeared on NPR. She earned her bachelor’s degree from Brown University and her doctorate degree from Brandeis University, where she studied the history of science and technology.
Tom Donovan brings to Ten Bridge experience from multiple assignments in London, Australia and New Zealand. His most recent role was as director of communications for Nexvet Biopharma, a NASDAQ-listed biotechnology company that was acquired by Zoetis in 2017. Leading to acquisition, Tom worked with the company's executive team across all aspects of corporate and investor communications, from its early funding rounds, re-incorporation in Ireland, global operational expansion and IPO. Prior to this, Tom worked in a variety of communications consultant or policy roles to private biotech companies and government innovation teams in Australia, including development of the Global Health Melbourne Plan. Prior to this, Tom worked in investor and public relations consultancy roles with ASX-listed biotechnology companies, and as a junior business journalist in New Zealand. Tom has a bachelor's degree in biomedical science and a master's degree (1st class honors) in bioscience enterprise, both from the University of Auckland.